This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Hye-Sung Lee: Innovator in Pharmaceutical Chemistry
Introduction
Hye-Sung Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications.
Latest Patents
Hye-Sung Lee holds a patent for a compound titled "5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof." This invention provides a novel derivative of 5-carbamoyl adamantan-2-yl amide, or a pharmaceutically acceptable salt thereof. The compound is designed for pharmaceutical use in inhibiting the activity of 11β-hydroxysteroid dehydrogenase type 1 (11b-HSD1) and for preventing and/or treating various diseases mediated by this enzyme. He has 1 patent to his name.
Career Highlights
Hye-Sung Lee is currently associated with Sk Biopharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions in the pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues such as Kyung-Seok Oh and Choon-Ho Ryu, contributing to a dynamic research environment that fosters innovation.
Conclusion
Hye-Sung Lee's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in treating diseases through novel compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile